• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可降解葡聚糖纳米聚合物作为胆碱激酶(ChoK)小干扰RNA癌症治疗的载体

Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy.

作者信息

Chen Zhihang, Krishnamachary Balaji, Bhujwalla Zaver M

机构信息

JHU ICMIC Program, Division of Cancer Imaging Research, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

Nanomaterials (Basel). 2016 Feb 22;6(2):34. doi: 10.3390/nano6020034.

DOI:10.3390/nano6020034
PMID:28344291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5302479/
Abstract

Although small interfering RNA (siRNA) therapy has proven to be a specific and effective treatment in cells, the delivery of siRNA is a challenge for the applications of siRNA therapy. We present a degradable dextran with amine groups as an siRNA nano-carrier. In our nano-carrier, the amine groups are conjugated to the dextran platform through the acetal bonds, which are acid sensitive. Therefore this siRNA carrier is stable in neutral and basic conditions, while the amine groups can be cleaved and released from dextran platform under weak acid conditions (such as in endosomes). The cleavage and release of amine groups can reduce the toxicity of cationic polymer and enhance the transfection efficiency. We successfully applied this nano-carrier to deliver choline kinase (ChoK) siRNA for ChoK inhibition in cells.

摘要

尽管小干扰RNA(siRNA)疗法已被证明在细胞中是一种特异性且有效的治疗方法,但siRNA的递送仍是siRNA疗法应用面临的一个挑战。我们提出了一种带有胺基的可降解葡聚糖作为siRNA纳米载体。在我们的纳米载体中,胺基通过酸敏感的缩醛键与葡聚糖平台相连。因此,这种siRNA载体在中性和碱性条件下是稳定的,而胺基在弱酸条件下(如在内体中)可从葡聚糖平台上裂解并释放出来。胺基的裂解和释放可以降低阳离子聚合物的毒性并提高转染效率。我们成功地应用这种纳米载体递送胆碱激酶(ChoK)siRNA以在细胞中抑制ChoK。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/5302479/3db517dc5bb8/nanomaterials-06-00034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/5302479/70eeb6b1ae55/nanomaterials-06-00034-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/5302479/2fe164680257/nanomaterials-06-00034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/5302479/2ed2089cc18a/nanomaterials-06-00034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/5302479/3db517dc5bb8/nanomaterials-06-00034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/5302479/70eeb6b1ae55/nanomaterials-06-00034-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/5302479/2fe164680257/nanomaterials-06-00034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/5302479/2ed2089cc18a/nanomaterials-06-00034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/5302479/3db517dc5bb8/nanomaterials-06-00034-g003.jpg

相似文献

1
Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy.可降解葡聚糖纳米聚合物作为胆碱激酶(ChoK)小干扰RNA癌症治疗的载体
Nanomaterials (Basel). 2016 Feb 22;6(2):34. doi: 10.3390/nano6020034.
2
Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation.酸降解的葡聚糖作为 COX-2 下调的图像引导 siRNA 载体。
Theranostics. 2018 Jan 1;8(1):1-12. doi: 10.7150/thno.21052. eCollection 2018.
3
Acid-degradable polymer-caged lipoplex (PCL) platform for siRNA delivery: facile cellular triggered release of siRNA.酸降解聚合物包裹的脂质体(PCL)平台用于 siRNA 递送:细胞触发 siRNA 的简便释放。
J Am Chem Soc. 2013 Nov 27;135(47):17655-8. doi: 10.1021/ja404491r. Epub 2013 Nov 13.
4
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles.酸降解阳离子纳米水凝胶颗粒介导的体内基因 RNA 干扰。
J Control Release. 2017 Feb 28;248:10-23. doi: 10.1016/j.jconrel.2016.12.006. Epub 2016 Dec 9.
5
Acid-degradable cationic poly(ketal amidoamine) for enhanced RNA interference in vitro and in vivo.酸降解阳离子聚(酮缩氨醛酰胺)用于增强体外和体内的 RNA 干扰。
Biomacromolecules. 2013 Jan 14;14(1):240-7. doi: 10.1021/bm301669e. Epub 2013 Jan 2.
6
Conjugation chemistry through acetals toward a dextran-based delivery system for controlled release of siRNA.通过缩醛的连接化学构建基于葡聚糖的给药系统用于 siRNA 的控制释放。
J Am Chem Soc. 2012 Sep 26;134(38):15840-8. doi: 10.1021/ja305552u. Epub 2012 Sep 18.
7
Visible light-switched cytosol release of siRNA by amphiphilic fullerene derivative to enhance RNAi efficacy in vitro and in vivo.两亲性富勒烯衍生物介导的可见光开关型siRNA胞质释放以增强体内外RNA干扰效果
Acta Biomater. 2017 Sep 1;59:158-169. doi: 10.1016/j.actbio.2017.05.031. Epub 2017 May 13.
8
PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation.具有葡聚糖纳米颗粒的PD-L1小分子干扰RNA诊疗技术凸显了纳米颗粒递送对有效下调肿瘤PD-L1的重要性。
Front Oncol. 2021 Feb 25;10:614365. doi: 10.3389/fonc.2020.614365. eCollection 2020.
9
Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.双功能化氧化石墨烯增强 siRNA 递送至乳腺癌细胞。
Colloids Surf B Biointerfaces. 2016 Nov 1;147:315-325. doi: 10.1016/j.colsurfb.2016.08.015. Epub 2016 Aug 12.
10
Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.一种近红外荧光碳菁对胆碱激酶的直接抑制作用。
Mol Cancer Ther. 2014 Sep;13(9):2149-58. doi: 10.1158/1535-7163.MCT-14-0085. Epub 2014 Jul 15.

引用本文的文献

1
Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression.胆碱水平升高驱动 KLF5 主导的转录重编程,促进肝癌进展。
Oncogene. 2024 Oct;43(42):3121-3136. doi: 10.1038/s41388-024-03150-w. Epub 2024 Sep 9.
2
Construction of GPC3-modified Lipopolymer SiRNA Delivery System.构建 GPC3 修饰的脂质体 siRNA 递药系统。
Curr Pharm Des. 2024;30(19):1507-1518. doi: 10.2174/0113816128258852231204102044.
3
Dextran Formulations as Effective Delivery Systems of Therapeutic Agents.葡聚糖制剂作为治疗剂的有效传递系统。

本文引用的文献

1
Bio-inspired pulmonary surfactant-modified nanogels: A promising siRNA delivery system.仿生肺表面活性剂修饰纳米胶束:一种有前途的 siRNA 递送系统。
J Control Release. 2015 May 28;206:177-86. doi: 10.1016/j.jconrel.2015.03.015. Epub 2015 Mar 17.
2
Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages.纳米颗粒在上皮细胞和巨噬细胞中有不同的内吞摄取机制。
Beilstein J Nanotechnol. 2014 Sep 24;5:1625-36. doi: 10.3762/bjnano.5.174. eCollection 2014.
3
Hydrogel doped with nanoparticles for local sustained release of siRNA in breast cancer.
Molecules. 2023 Jan 21;28(3):1086. doi: 10.3390/molecules28031086.
4
PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation.具有葡聚糖纳米颗粒的PD-L1小分子干扰RNA诊疗技术凸显了纳米颗粒递送对有效下调肿瘤PD-L1的重要性。
Front Oncol. 2021 Feb 25;10:614365. doi: 10.3389/fonc.2020.614365. eCollection 2020.
5
The PD-L1 metabolic interactome intersects with choline metabolism and inflammation.程序性死亡配体1(PD-L1)代谢相互作用组与胆碱代谢和炎症相互交叉。
Cancer Metab. 2021 Feb 19;9(1):10. doi: 10.1186/s40170-021-00245-w.
6
MicroRNA-367-3p induces apoptosis and suppresses migration of MCF-7 cells by downregulating the expression of human choline kinase α.微小RNA-367-3p通过下调人胆碱激酶α的表达诱导MCF-7细胞凋亡并抑制其迁移。
Oncol Lett. 2021 Mar;21(3):183. doi: 10.3892/ol.2021.12444. Epub 2021 Jan 6.
7
Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.癌症精准纳米医学中的治疗性小干扰 RNA 纳米颗粒
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1595. doi: 10.1002/wnan.1595. Epub 2019 Oct 23.
8
Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy.仿生磁性纳米载体将胆碱激酶α抑制剂输送到癌细胞内用于联合化疗-热疗。
Pharmaceutics. 2019 Aug 12;11(8):408. doi: 10.3390/pharmaceutics11080408.
9
Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells.胆碱激酶抑制剂 EB-3D 和 EB-3P 干扰 HepG2 细胞中的脂质稳态。
Sci Rep. 2019 Mar 25;9(1):5109. doi: 10.1038/s41598-019-40885-z.
10
Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon.基于聚乙烯亚胺的纳米载体用于药物和基因的共递送:发展前景
Nano Rev Exp. 2018 Jul 3;9(1):1488497. doi: 10.1080/20022727.2018.1488497. eCollection 2018.
水凝胶负载纳米颗粒用于乳腺癌局部siRNA 的持续释放。
Adv Healthc Mater. 2015 Jan 28;4(2):271-80. doi: 10.1002/adhm.201400235. Epub 2014 Aug 11.
4
Quantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution.在可控生物条件下及具备足够分辨率的情况下对金纳米颗粒细胞摄取量进行定量分析。
Nanomedicine (Lond). 2014 Apr;9(5):607-21. doi: 10.2217/nnm.13.24. Epub 2013 Jun 5.
5
Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNA.用于体内系统递送和肿瘤靶向 siRNA 的抗蛋白、还原可解离的聚合物复合物。
Biomaterials. 2013 Mar;34(9):2370-9. doi: 10.1016/j.biomaterials.2012.12.004. Epub 2013 Jan 5.
6
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles.医学纳米粒子表面电荷在细胞摄取和细胞毒性中的作用。
Int J Nanomedicine. 2012;7:5577-91. doi: 10.2147/IJN.S36111. Epub 2012 Nov 2.
7
Conjugation chemistry through acetals toward a dextran-based delivery system for controlled release of siRNA.通过缩醛的连接化学构建基于葡聚糖的给药系统用于 siRNA 的控制释放。
J Am Chem Soc. 2012 Sep 26;134(38):15840-8. doi: 10.1021/ja305552u. Epub 2012 Sep 18.
8
PSMA-targeted theranostic nanoplex for prostate cancer therapy.PSMA 靶向治疗性纳米复合物用于前列腺癌治疗。
ACS Nano. 2012 Sep 25;6(9):7752-7762. doi: 10.1021/nn301725w. Epub 2012 Aug 9.
9
A review of nanocarriers for the delivery of small interfering RNA.纳米载体用于小干扰 RNA 递送的研究综述。
Biomaterials. 2012 Oct;33(29):7138-50. doi: 10.1016/j.biomaterials.2012.06.068. Epub 2012 Jul 12.
10
Primer3--new capabilities and interfaces.Primer3--新功能和界面。
Nucleic Acids Res. 2012 Aug;40(15):e115. doi: 10.1093/nar/gks596. Epub 2012 Jun 22.